FORTUNATO, Fernanda
 Distribuzione geografica
Continente #
NA - Nord America 384
EU - Europa 117
AS - Asia 103
AF - Africa 2
Totale 606
Nazione #
US - Stati Uniti d'America 382
IT - Italia 60
SG - Singapore 44
CN - Cina 43
DE - Germania 22
ID - Indonesia 11
GB - Regno Unito 10
FI - Finlandia 7
SE - Svezia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
SI - Slovenia 3
UA - Ucraina 3
CA - Canada 2
DZ - Algeria 2
VN - Vietnam 2
BD - Bangladesh 1
IN - India 1
LT - Lituania 1
NL - Olanda 1
TR - Turchia 1
Totale 606
Città #
Chandler 66
Fairfield 54
Ashburn 37
Ferrara 30
Singapore 29
Beijing 18
Seattle 15
Cambridge 14
Shanghai 14
Woodbridge 14
Houston 12
New York 12
Jakarta 11
Bremen 9
Princeton 9
Wilmington 9
Munich 8
San Diego 8
Los Angeles 7
Milan 6
Falls Church 5
Helsinki 5
Santa Clara 5
Ann Arbor 4
Boardman 4
Bologna 3
Brno 3
Jacksonville 3
Rome 3
Brussels 2
Dearborn 2
Dong Ket 2
Guangzhou 2
Hounslow 2
London 2
Nanjing 2
Shenyang 2
Toronto 2
Addison 1
Amsterdam 1
Chicago 1
Cingoli 1
Espoo 1
Falkenstein 1
Ferrara di Monte Baldo 1
Frankfurt am Main 1
Hyderabad 1
Izmir 1
Kilburn 1
Lacco Ameno 1
Lappeenranta 1
Leawood 1
Lowell 1
Norwalk 1
Orange 1
Padova 1
Redwood City 1
San Mateo 1
Washington 1
Totale 456
Nome #
A CMT2 family carrying the P7R mutation in the N- terminal region of the HSPB1 gene 82
DMD gene molecular genetic characterization in Eastern Europe and non European countries 80
Report of a novel ATP7A mutation causing distal motor neuropathy 76
Ethnicity-related DMD Genotype Landscapes in European and Non-European Countries 71
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection 64
Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy 52
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 49
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI 31
Three-years follow up of raltegravir and/or maraviroc-based regimens in patients experienced to PI, NRTI, NNRTI. Update from the ISS-NIA cohort 29
Rare diseases' genetic newborn screening as the gateway to future genomic medicine: the Screen4Care EU-IMI project 20
AFG3L2 Biallelic Mutation: Clinical Heterogeneity in Two Italian Patients 19
TeleNEwCARe: An Italian case-control telegenetics study in patients with Hereditary NEuromuscular and CARdiac diseases 15
Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe 13
The DMD gene and therapeutic approaches to restore dystrophin 12
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience 10
DMD deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis 10
mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies 8
Totale 641
Categoria #
all - tutte 5.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 0 4 5 8 12 8 19 14 9 4
2020/2021102 1 9 0 12 1 12 7 18 7 8 18 9
2021/202293 1 13 0 2 8 6 1 0 12 11 4 35
2022/2023131 12 22 4 13 24 11 5 11 23 1 3 2
2023/2024126 7 11 5 1 11 22 4 10 15 4 3 33
2024/202591 20 13 37 21 0 0 0 0 0 0 0 0
Totale 641